C. Peters

发表

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial

L. Kachnic, C. Langer, L. Berk, 2018, Annals of Nuclear Medicine.

Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study

M. Klem, T. Churilla, H. Brereton, 2011, BMJ Open.

Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case e control study

M. Klem, T. Churilla, H. Brereton, 2022 .

Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.

R. Stock, N. Stone, J. Cesaretti, 2006, International journal of radiation oncology, biology, physics.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, S. Yeung, 2022, npj Digital Medicine.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Christopher U. Jones, K. Pienta, H. Sandler, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Early-stage Hodgkin disease in a 24-year-old woman.

J. Vose, E. Glatstein, C. Peters, 2011, Seminars in oncology.

Changes in prostate-specific antigen midway through salvage radiotherapy may be associated with long-term outcomes

H. Brereton, C. Peters, Jason M. Homza, 2019, Journal of Radiation Oncology.

Effect of Chronic Hematologic Malignancies on In-Hospital Outcomes of Patients With ST-Segment Elevation Myocardial Infarction.

S. Pancholy, C. Peters, A. Amin, 2019, The American journal of cardiology.

Analysis of a biopsy-based genomic classifier in high-risk prostate cancer: Meta-analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials.

H. Sandler, F. Feng, D. Spratt, 2022, International journal of radiation oncology, biology, physics.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

R. Hannan, H. Sandler, J. Purdy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.

D. Grignon, H. Sandler, Q. Zhang, 2013, International journal of radiation oncology, biology, physics.

Long-term results of local recurrence after breast conservation treatment for invasive breast cancer.

D. Schultz, L. Solin, E. Harris, 2001, International journal of radiation oncology, biology, physics.

Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast.

D. Schultz, L. Solin, E. Harris, 2000, International journal of radiation oncology, biology, physics.

Post-thrombocythemic myeloid metaplasia with pleural involvement and the duration of response to external beam radiation therapy: a case report and literature review

B. Saidman, T. Churilla, C. Peters, 2012, Journal of Radiation Oncology.

Vitamin D Deficiency Is Widespread in Cancer Patients and Correlates With Advanced Stage Disease: A Community Oncology Experience

M. Klem, T. Churilla, H. Brereton, 2011, Nutrition and cancer.

A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.

Christopher A Peters, Barry S Rosenstein, R. Stock, 2007, International journal of radiation oncology, biology, physics.

Superior vena cava syndrome arising from a solitary metastasis to an indwelling catheter.

T. Churilla, H. Brereton, C. Peters, 2011, Clinical radiology.

Association of Single Nucleotide Polymorphisms in SOD2, XRCC1 and XRCC3 with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer

Christopher A Peters, Barry S Rosenstein, Grace Fan, 2008, Radiation research.

Total Mastectomy or Breast Conservation Therapy? How Radiation Oncologist Accessibility Determines Treatment Choice and Quality: A SEER Data‐base Analysis

Erin R. Leatherman, T. Churilla, C. Peters, 2015, The breast journal.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, M. Lungren, 2022, npj Digital Medicine.

TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.

H. Ostrer, R. Stock, N. Stone, 2008, International journal of radiation oncology, biology, physics.

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities

I. Hsu, E. Horwitz, D. D'Souza, 2018, Advances in radiation oncology.

Clinical implementation of radiosurgery using the Helical TomoTherapy unit.

C. Saw, C. Peters, L. Koutcher, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Single Nucleotide Polymorphisms as Predictors for Development of Erectile Dysfunction in African-American Men Treated With Radiotherapy for Prostate Cancer

R. Stock, N. Stone, J. Cesaretti, 2007 .

Total Mastectomy or Breast Conservation Therapy? How Radiation Oncologist Accessibility Determines Treatment Choice and Quality: A SEER Data‐base Analysis

Erin R. Leatherman, T. Churilla, C. Peters, 2015, The breast journal.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Christopher U. Jones, K. Pienta, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.

R. Stock, N. Stone, C. Peters, 2009, International journal of radiation oncology, biology, physics.